Gary Owens, MD, president of Gary Owens Associates, explains the importance of shared decision making and patient-centered care in pulmonary arterial hypertension (PAH).
Managing pulmonary arterial hypertension really takes a health care team, said Gary Owens, MD, president of Gary Owens Associates.
Transcript
How important is shared decision making and patient-centered care in pulmonary arterial hypertension (PAH)?
You know, I think it really probably is one of the most important things that one can bring, because you really do need to bring the patient into the decision of exactly what their goals are. How, I won't say how aggressive, but how symptomatic they are. And how much treatment, they're willing to tolerate. The combinations of 3—and sometimes even 4—drugs can be pretty complex and costly, and patients need to understand that impact. So I think it comes into play.
I think what also comes into play, when you talk about shared [decision making] is kind of sharing that understanding that managing pulmonary arterial hypertension really takes a health care team. You know, the primary care provider still needs to play a role to help coordinate and be a medical home, obviously, the pulmonologist or, in this case, the pulmonologist at an advanced care setting that deals with pulmonary arterial hypertension, needs to be involved, and maybe cardiology involved. And these patients sometimes have other comorbidities.
So it really points out, you know, shared decision making on the patient's part. But the other side of that coin is shared responsibility on the part of providers and then payers basically need to look at their formularies, make sure those formularies keep up with guidelines, and make sure that they're staying on top of the latest data and treatment approaches as the guidelines change fairly quickly these days.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More